Toyota Motor
7203
CellSeed
7776
Metaplanet
3350
4
Nippon Telegraph & Telephone
9432
5
Note
5243
JP Stock MarketDetailed Quotes
4563 AnGes
- 69
- 00.00%
20min DelayMarket to Open Mar 27 15:30 JST
22.57BMarket Cap-0.58P/E (Static)
0High0Low0Volume0Open69Pre Close0.00Turnover9852wk High0.00%Turnover Ratio327.07MShares4352wk Low-119.53EPS TTM21.75BFloat Cap5596Historical HighLossP/E (Static)315.26MShs Float43Historical Low-119.53EPS LYR0.00%Amplitude--Dividend TTM9.16P/B100Lot Size--Div YieldTTM
About AnGes Company
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Company Profile
Symbol4563
Company NameAnGes
Founded1999-12-17
MarketTSE Growth
Employees55
Fiscal Year Ends12-31
Address7-7-15, Saito-asagi 4F, Saito Bio-Incubator
Zip Code108-0014
Phone---
Websitewww.anges.co.jp
Company Executives
- Name
- Position
- Salary
- Ei Yamada
- Representative Director , President and Chief Executive Officer
- --
- Shoya Satou
- Director
- --
- Norikazu Eiki
- Independent Director
- --
- Makoto Hara
- Independent Director
- --
- Kimiko Murofushi
- Independent Director
- --
- Junichi Komamura
- Independent Director
- --